HPV legislation in Oklahoma

From SourceWatch
Jump to: navigation, search

Women in Government Ratings

Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" [1]:


POPULATION: 3,579,212


Incidence & Mortality (2008 Score / 2007 Score)

  • Cervical Cancer Incidence Rate: 9.4/100,000 (1/ 1)
  • Cervical Cancer Incidence Rate/Race: White: 9.4, Black: 13.8, Hispanic: 16.1, American Indian/Alaskan: 14.5
  • Cervical Cancer Mortality Rate: 2.6/100,000 (1 / 1)
  • Cervical Cancer Mortality Rate/Race: White: 2.4, Black: 3.2, American Indian/Alaskan: 4.3


Screening (2008 Score / 2007 Score)

  • Cervical Cancer Screening Rate: 79.4% (0 / 1)
  • Cervical Cancer Screening Rate/Race: White: 79.3%, Black: 82.9%, Hispanic: 81.1%, American Indian/Alaskan: 82.9%
  • % Uninsured/Unscreened: 27.4% (1 / 1)
  • Medicaid Coverage HPV Testing: Unrestricted (2 / 2)


Healthcare Access (2008 Score / 2007 Score)

  • Rate Uninsured Women: 27.4% (0 / 0)
  • % Low Income/Uninsured Women: 43%


Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 0)

  • There are no new screening requirements.

Task Forces (2 / 2)

  • There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)

  • SB 487 would require girls entering the 6th grade to receive the HPV vaccination; referred to Rules Committee.

HPV Vaccine Information Programs (0 / 0)

  • There is no HPV vaccine information activity.

Miscellaneous (0 / 2)

  • There is no new miscellaneous cervical cancer prevention activity.


Annual Ratings

  • 2008: Fair (10 out of 22 points)
  • 2007: Good (10 out of 18 points)


Articles and resources

SourceWatch Resources

External links

References